Browse Biotechnology industry topic

Joint ventures subtopic

Articles 1-98 out of 98 article(s) Title Author Type Date Words Joint venture. Brief article Dec 1, 2009 71 France : Avesthagen forms JV with French co-operative group. Nov 2, 2009 191 Maxygen Announces Consummation of Joint Venture Transaction With Astellas. Sep 21, 2009 802 India : Best Roses Biotech forms JV with Malaysian firm. Sep 11, 2009 326 French drugmaker opens Havana office to pursue Cuba JVS. Echevarria, Vito Jul 1, 2009 326 Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals. Jun 30, 2009 1826 INTERVIEW: Alltech President Foresees End of MSG as Company Partners Japanese Ingredient JV. Interview Mar 12, 2009 802 Genus to link with China scandal firm; BIOTECHNOLOGY. Feb 20, 2009 148 Joint Venture Between CHA Biotech and Advanced Cell Technology to be called "Stem Cell & Regenerative Medicine International". Dec 30, 2008 379 Business briefs. Dec 2, 2008 219 Leading Korean Biotech Company & Advanced Cell Technology Form JV. Dec 1, 2008 970 Regulus Therapeutics Selected for Fierce 15 Top Biotech Companies. Jun 24, 2008 1240 Australia : Murdoch in drug analysis JV with Malaysian research group. May 8, 2008 332 Universidad de Chile obtains United States patent. Brief article Jan 1, 2008 189 Monsanto. Brief article Mar 12, 2007 59 Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE. Feb 20, 2007 1153 Health Discovery Corporation and Atlantic Alpha Strategies, LLC Announce Formation of Joint Venture. Jan 23, 2007 590 Amgen in joint venture for heart drug: Cytokinetics deal lowers financial risk. Coates, Chris Jan 8, 2007 643 Affymetfix launched the GeneChip Globin-Reduction kits and protocol developed in conjunction with PreAnalytiX GmbH, a joint venture between QIAGEN and Becton, Dickinson and Company. Aug 15, 2005 39 US BioTec Inc. Brief Article Jul 1, 2005 59 In March, Geneva Bioinformatics SA (GeneBio) and Current Science Group formed Current BioData, which will develop and distribute GeneBio's ProXenter Protein Exploration Center. Brief Article Jun 15, 2005 51 Metabolon collaborates on biomarker study for Huntington's Disease. Jan 1, 2005 413 Medtronic, Genzyme form joint venture to develop new treatments for cardiac repair. Brief Article Jun 14, 2004 216 AngioGenetics AB and Tumor Biology Center Freiburg collaborate on the exploration of angiogenesis inhibitors for cancer treatment. Jun 1, 2004 348 Medtronic, Genzyme form joint venture to target cardiac repair. May 1, 2004 1146 As a part of a joint collaboration, NuGEN Technologies develop its Whole Transcript Amplification. Brief Article Mar 15, 2004 22 In a 10Q filing with the SEC, Affymetrix disclosed the details of Array Automation, LLC (AAL), its joint venture with Beckman Coulter (see IBO 10/31/03). Brief Article Jan 31, 2004 80 ThermoGenesis, Mediware to develop and market fully integrated cell therapy system. Brief Article Nov 15, 2003 114 Analytica of Branford and Amersham part ways. (Executive briefing: news, trends & market intelligence for instrument executives). Brief Article Jun 15, 2003 95 Discovery Genomics and AngioGenetics joint venture. Brief Article Jul 1, 2002 359 U.S. Microbics Signs 6-State Exclusive Agreement. Zion, Lee Brief Article Jul 9, 2001 163 MICRO AND NANO TECHNOLOGIES. Feb 1, 2001 203 Affymetrix to provide technology to New York research institutions. Apr 1, 2000 700 QUARK SIGNS RESEARCH PACT WITH SHIONOGI. Mar 1, 2000 409 Davisco Foods International, Advitech Solutions Join Forces to Produce Whey Protein Hydrolyzates. Oct 12, 1998 899 Human Medical Options (Latin America) S.A. Panama Makes Announcement. Aug 25, 1998 333 Glyko Biomedical Ltd. Announces that its 41%-owned Subsidiary, BioMarin Pharmaceutical, Inc., and Genzyme Sign Letter of Intent to Develop New Product to Treat Fatal Genetic Disease. Jun 4, 1998 1008 Geron Forms Collaboration with Boehringer Mannheim to Develop and Commercialize New Class of Cancer Diagnostics; Agreement Focuses on Advances in Telomerase Detection Technologies. Dec 22, 1997 585 VIMRX Stockholders Approve Formation of New Cell Therapy Company. Dec 16, 1997 364 Terrapin and Pharmagene Announce Drug Screening Alliance. Nov 21, 1997 563 Merck & Co., Inc. and Karo Bio AB Enter Into a Strategic Alliance. Nov 3, 1997 621 Molecular Dynamics and Amersham Pharmacia Biotech Sign DNA Microarray Technology Access Agreement with DuPont Agricultural Products. Oct 20, 1997 952 VIMRX and Baxter Sign Definitive Agreement to Form New Cell Therapies Company. Oct 13, 1997 1526 Cell Therapeutics and R.W. Johnson Pharmaceutical Research Institute Expand Their Collaboration For Lisofylline Development to Include Acute Myeloid Leukemia. Sep 22, 1997 781 Chiroscience and Geron Form Joint Research Collaboration Around Gene For Premature Aging. Sep 15, 1997 727 Helix BioPharma Corp. and Pence Announce Third Research and Development Partnership. Aug 5, 1997 895 Xenometrix, Inc. and Oncogene Science, Inc. form strategic alliance to develop state-of-the-art lead prioritization technologies. Jul 1, 1997 625 Perkin-Elmer and Hyseq collaborate to accelerate the development of DNA chip technology. Jun 19, 1997 737 Advanced Pharmaceuticals enters joint venture with DCV, a Du Pont/Con Agra company. May 13, 1997 335 Pharmex expands into drug discovery market. Apr 3, 1997 589 Sequana Therapeutics and PE Applied Biosystems to establish China's first large-scale DNA sequencing center. Jan 20, 1997 869 Lilly and TheraTech announce multiproduct peptide delivery development agreement. Jan 14, 1997 450 Suntory Ltd. and ICOS Corp. announce the formation of a joint venture company. Jan 8, 1997 587 Lilly and Aurora enter into a collaboration agreement involving ultra-high-throughput screening technology. Jan 3, 1997 448 ILEX Oncology and MPI Development form joint venture to develop anticancer compound. Jan 2, 1997 396 Hawaii's oldest company announces joint venture with Aquasearch, marine bioscience leader on the Big Island. Nov 13, 1996 1291 Varian, Stanford, SRI International Join in Cell Research Aimed at New Cancer Cures. Oct 21, 1996 423 Biopharmaceutics Announces Cancer Drug Joint Venture Revenue Percentage. Sep 26, 1996 133 Biopharmaceutics signs agreement for Mitolactol joint venture. Sep 25, 1996 427 ImmuCell forms joint venture with Membrex to sell Crypto-Scan drinking-water test; 'Clearwater Diagnostics Company' will offer the new test, which detects presence of Cryptosporidium now menacing nation's water supply. Sep 18, 1996 427 Biopharmaceutics Signs Letter of Intent to Develop Cancer Drug. Sep 17, 1996 255 Sugen and Arqule to Collaborate on Novel Signal Transduction Inhibitors. Sep 5, 1996 430 Cancer genetics joint venture formed by Memorial Sloan-Kettering and Sequana. Aug 20, 1996 1200 NutraGenics Announces Multi-Million Dollar Joint Venture. Aug 6, 1996 300 HemoCleanse and VivoRx Pharmaceuticals announce agreement to develop and market innovative bioartificial liver; porcine liver cell product, HepatoRx, to be used with 510k approved liver assist device. Jul 30, 1996 351 Wright Medical Technology, Inc. enters into agreement with Tissue Engineering Inc. Jul 22, 1996 409 ImmuCell announces intent to form joint venture with Agri-Mark. Jul 11, 1996 335 Lynx Therapeutics Inc. Enters Into Collaboration Agreement with Tanabe Seiyaku Co. Ltd. Jul 10, 1996 425 Chiron and Behringwerke Complete Joint Venture in Vaccines, to be Known as Chiron Behring. Jul 2, 1996 886 Sugen, Inc. and the Institutes of Botany and Microbiology of the Chinese Academy of Sciences to Collaborate on the Screening of Broad Plant and Microbial Extract Collections Against SUGEN's Signal Transduction Targets. Jul 2, 1996 315 Vical and Corixa to collaborate on cancer gene therapy. May 15, 1996 420 Gryphon Sciences Signs Collaboration with SmithKline Beecham. Apr 29, 1996 355 Baxter and Steritech Finalize Comprehensive Agreement to Develop Pathogen Inactivation Systems for Blood. Apr 23, 1996 384 Neoprobe announces joint venture with Peptor to develop cancer detection and therapy products. Apr 17, 1996 494 ImmuCell announces alliance to further develop antibody product against cryptosporidiosis. Mar 26, 1996 482 GroupMed International announces joint venture contract with Pathology Laboratories Inc. Mar 20, 1996 159 Techniclone and Cambridge Antibody Technology announce joint venture to develop and commercialize new products for cancer therapy and diagnosis. Feb 6, 1996 825 HMO-biotech partnerships failing to materialize. Grove, Christopher Jan 22, 1996 956 Alta Genetics Inc. completes Altapon joint venture in Europe. Jan 9, 1996 334 Hygenics signs letter-of-intent with Biocontrol Inc. to form a joint R&D venture. Dec 13, 1995 301 Glaxo Wellcome to develop British Biotech anti-arthritic drug. Sep 27, 1995 565 Somatogen receives Lilly milestone payment and amends global strategic alliance. Sep 18, 1995 270 New Arris collaboration with Pharmacia applies Delta technology to clotting cascade. Sep 5, 1995 477 Human Genome Sciences and MedImmune form alliance to develop antibacterial vaccines and immunotherapeutics; completes genome sequence of first target organism Haemophilus influenzae reported in tomorrow's (July 28) Science. Jul 27, 1995 672 Genelabs and the Taiwan, ROC Ministry of Finance announce investment plan in Genelabs Biotechnology Limited. Jul 14, 1995 459 Medizone announces New Zealand joint venture. Jun 28, 1995 482 Sequana Therapeutics and Boehringer Ingelheim form asthma research alliance. Jun 14, 1995 733 Matritech and Bayer to develop novel cervical cancer test. Jun 14, 1995 899 SIBIA and Eli Lilly extend research agreement for discovery of calcium channel drugs. Jun 13, 1995 427 Isis and Carlsbad forging biotech partnership. Fikes, Bradley J. May 22, 1995 719 CORT MACKENZIE & THOMAS starts joint venture in China. May 15, 1995 334 Sequana Therapeutics and Corange to join forces to identify osteoporosis genes. May 4, 1995 405 Joint venture between Novo Nordisk and Chinese company. Apr 10, 1995 441 Chiron and Progenitor, an Interneuron subsidiary, to collaborate in gene therapy. Apr 4, 1995 1054 METRA BIOSYSTEMS AND SUMITOMO PHARMACEUTICALS SIGN COLLABORATIVE AGREEMENT FOR ALKPHASE-B(TM). Mar 2, 1995 398 Martek and Neuromedica sign agreement to produce tardive dyskinesia drug to pass through the blood brain barrier; second agreement also signed. Feb 14, 1995 613 ImmuLogic announces additional milestone payment from Marion Merrell Dow. Jan 12, 1995 294 RiboGene Announces Collaboration with Warner-Lambert to Discover New Antiviral Drugs. Jan 5, 1995 316